WHO Expert Committee on Specifications for Pharmaceutical Preparations (Record no. 83549)
| 000 -LEADER | |
|---|---|
| fixed length control field | 02901nam a2200349Ia 4500 |
| 245 00 - TITLE STATEMENT | |
| Title | WHO Expert Committee on Specifications for Pharmaceutical Preparations |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication | Geneva : |
| Name of publisher | World Health Organization, |
| Year of publication | 2006. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Number of Pages | x, 461 p. : |
| Other physical details | ill. |
| 490 1# - SERIES STATEMENT | |
| Series statement | WHO technical report series ; |
| 500 ## - GENERAL NOTE | |
| General note | "WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 24-28 October 2005"--P. vii. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | This report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. Annexes include: a list of available international chemical reference substances and international infrared spectra; supplementary guidelines on good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical dosage forms; updated supplementary guidelines on good manufacturing practices for the manufacture of herbal medicines; supplementary guidelines on good manufacturing practices for validation; good distribution practices for pharmaceutical products; a model quality assurance system for procurement agencies (recommendations for quality assurance systems focusing on prequalification of products and manufacturers, purchasing, storage and distribution of pharmaceutical products); multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability; a proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms; and additional guidance for organizations performing in vivo bioequivalence studies. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Term | Drugs |
| Topical Term | Pharmacopoeias |
| Topical Term | Drugs |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://site.ebrary.com/lib/rucke/Doc?id=10137826 |
No items available.